VAERS Explorer
Back to explore

Report #2824721

Received Feb 5, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
2 yrs
State
CA
Recovered
Recovered
Vaccinated
Jun 7, 2024
Onset
Jun 7, 2024
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
MNQMENINGOCOCCAL CONJUGATE (MENVEO)NOVARTIS VACCINES AND DIAGNOSTICS1L7373IM / LL

Symptoms (1)

Product administered to patient of inappropriate age

Symptom narrative

Physician ordered Menveo 1-vial formulation for 2-year old patient in preparation for upcoming travel out of the country. Vaccine administered by LVN as ordered. Menveo 1-vial formulation is FDA-approved for ages 10-55 years. The prescribing information states "Safety and effectiveness of the one-vial presentation of MENVEO in children aged younger than 10 years have not been established. For children 2 months through 9 years of age, only the two-vial presentation is approved for use." The order in EMR reads "Meningococcal MCV40 (MENVEO) - 1 vial (10-55yr)". The vial states "10 years through 55 Years of Age".

Current illness

None

Medical history

None

Other medications

None

Allergies

None

Lab data

None